Navigation Links
Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
Date:9/10/2007

Managed Care Organizations Aggressively Control Access to Biologics,

According to a New Report from Decision Resources

WALTHAM, Mass., Sept. 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that specialists are turning to biologics earlier in the course of treatment for psoriasis and psoriatic arthritis. According to the new Physician & Payer Forum report entitled Psoriasis and Psoriatic Arthritis: The Expanding Biologics Landscape, surveyed dermatologists last year tried an average of 5.8 therapies for moderate psoriasis before turning to biologics. By mid-2008 they will try only 2.1 other therapies before turning to biologics. Likewise for axial psoriatic arthritis, rheumatologists tried an average of 4.1 other therapies prior to biologics last year; by mid-2008 they will only try 1.7 nonbiologics.

Specialists say the role of biologics will expand through mid-2008. Seventy-two percent of dermatologists and 90% of rheumatologists say they will write more scripts for biologics for psoriasis and psoriatic arthritis, respectively, through mid-2008. These specialists estimate that their use of biologics will increase by 9.9 percent in psoriasis and 11.9 percent in psoriatic arthritis.

In contrast to clinicians' increasingly aggressive use of biologics, the report also finds that managed care organizations (MCOs) are restricting access to biologics.

"By mid-2008, one half of surveyed MCOs' private plans will have step therapy protocols in place and 14 out of 20 surveyed MCOs will impose prior authorization for Enbrel, the leading biologic agent, for psoriasis therapy," said Joanna Kim, analyst at Decision Resources. "Physicians estimate that biologic therapy is currently delayed in 30-45% of their patients because of step therapy protocols imposed by MCOs. And overall, specialists perceive biologics to be less accessible for the tre
'/>"/>

SOURCE Decision Resources
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sonic closer to turning profit corner
2. Turning ads into sales: Context is king
3. Turning Around a Sick Company
4. GE Healthcare technology helping to detect Alzheimers earlier
5. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
6. Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns
7. Quintessence cancer treatment chosen for clinical studies
8. ZyStor to exhibit cell disorder treatments
9. Radiology advance points way to non-invasive brain-cancer treatment
10. Animal testing: Beyond the protests, instances of mistreatment are rare
11. TomoTherapy leads the industry in CT image-guided treatments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...LGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics ...or the "Company") today announced updated results ...n patients with sarcomas metastatic to the lung in...ve Tissue Oncology Society Meeting held in Miami B...r presentation, entitled "A Phase II Study of Intr...
(Date:11/5/2009)...ITHERSBURG, Md., Nov. 5 ...financial results for the third quarter ended Sept... million ($0.04 per share) for the three months en...6.8 million ($0.08 per share) in the comparable qu... 30, 2009, GenVec,s net loss was $14.1 million ($0...
(Date:11/5/2009)...NCHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall...ng supplier of innovative products for processing ...ts for the first quarter of fiscal 2010. ,, For... reported revenues of $5.2 million, a 15 percent i... quarter a year ago. The Company said the key cont...
(Date:11/5/2009)...NNYVALE, Calif., Nov. 5 ...executives will be speaking at the following inves...ate via webcast. , , Credit Suisse... Thursday, 12 November, 2009 at 10 a.m. Mountain...rogram, London, England, Tuesday, ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
Wisconsin's unusual Internet tax stirs dissent
...nal honors on Monday as President Bush gave medals...l R. de Boor and the Wisconsin Alumni Research Fo...nology transfer, respectively. , ,The 2003 Nation... accomplishments in various fields. They included ... Ethernet, and the work that led to the first auto...
...ags "wake up" when they,re near a reader and can s..., including its history, quantity, location and co...reds of major companies are scurrying to develop s...ication (RFID) technology after fall 2003 mandates...that their suppliers be RFID-compliant, tagging ca...
Other Biology Technology:UW-Madison workgroup helps state companies tap the power of RFID 2UW-Madison workgroup helps state companies tap the power of RFID 3UW-Madison workgroup helps state companies tap the power of RFID 4
(Date:11/9/2009)...wire/ -- CBS Vision, the research division of CBS ...a Group company, today announced a new research pa...the CBS Television City research facility housed i... venture, which marries the capabilities of CBS Vi...ll be called Communications Lab@OMD . ,, CBS,s...
(Date:11/9/2009)...ytoplankton are flourishing in areas of open water...ce shelves and glaciers around the Antarctic Penin...eficial impact on climate change. As the blooms di... can store carbon for thousands or millions of yea...l Change Biology , scientists from British Antarct...
(Date:11/9/2009)...nergy (DOE) has announced plans to fund research a...hool of Engineering on technologies that would hel...ure and permanent safe storage, or sequestration, ...ration with Southern Company, the parent company o... 2009 American Recovery and Reinvestment Act, the ...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Antarctica glacier retreat creates new carbon dioxide store 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 1Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 2Mersana Reports Preliminary Phase 1 Results of XMT 1001 in Patients with Advanced Solid Tumors 12387 3AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 1AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 2AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 12385 3UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 1UCB and Crohns Disease Working Group Award 24175 000 in Research Grants to Gastroenterology Fellows 12383 2
...ew research published online this week in the open...ic and much-studied question in the fruit fly, and...ls, male or female development depends on the pres...ales because it includes masculinizing genes. But .... James Erickson and Jerome Quintero at Texas A&M ...
...p to 20 meters long and weighing as much as 20 ton...don typus) its name. Known as the gentle giant fo...broad, flattened head and minute teeth, eats tiny ...ill-rakers. Listed as a rare species, relatively ...tropical and warm seas, including the western Atla...
... new targeted screening strategy could make the di...ble in low-resource settings, concludes a new stud...cess journal PLoS Neglected Tropical Diseases. , ...causes Chagas disease, is transmitted by triatomin... disease, which infects an estimated 11 million pe...
Other Biology News:Photo-monitoring whale sharks 2New screening strategy for detection of chagas disease in children 2
...IRsolution software provides quick and easy operat...-based control. The software is fully secure and ...lations, and compatible with user-created macros f...nables use in high-level research and development ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
...The PerkinElmer kit provides reagents for immune c...xes in serum and plasma samples using a combinatio...ized and transferred to microplate wells which are...tibody to HIV-1 p24. The immobilized monoclonal an...
Mitochondria Isolation Kit for Tissue and Cultured Cells from BioChain
Biology Products: